Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

CARSGEN-B

23.100
-0.250-1.07%
Volume:1.28M
Turnover:29.58M
Market Cap:13.31B
PE:-14.62
High:24.050
Open:24.000
Low:22.600
Close:23.350
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
CARSGEN-B
Exchange:
SEHK
Establishment Date:
2014
Employees:
465
Office Location:
Building 2,1st Floor,No. 466 Yindu Road,Xuhui District,Shanghai,China
Website:
http://www.carsgen.com
Zip Code:
- -
Phone:
86 21 6450 1828
Fax:
- -
Introduction:
CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company conducts its business in the domestic and overseas markets.

Directors

Name
Position
LI Zong Hai
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
WANG Hua Mao
Executive Director
JIANG Hua
Executive Director
YAN Guang Mei
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
ZHAO Xiang Ke
Independent Director,Chairman of the Audit Committee
ZHOU Wen
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee
GUO Bing Sen
Director
XIE Rong Gang
Director
GUO Hua Qing
Director,Member of the Audit Committee

Shareholders

Name
Position
LI Zong Hai
CEO,Chief Science Officer
Sylvie Peltier
Vice General Manager
WANG Hua Mao
COO
LV Ying Yi
Corporate Secretary
GU Jie
Other Senior Executives
Raffaele Baffa
Other Senior Executives